featured
-
Updates from uniQure about their gene therapy for Huntington's disease
10 min read
uniQure is conducting safety trials of the first gene therapy for HD. A recent press release provided a 1 year update on the first group of 10 people who underwent surgery to receive this experimental drug. Let’s talk more about what it means.
-
Artificial intelligence to save the day? How clever computers are helping us understand Huntington’s disease.
5 min read
Scientists at IBM and the CHDI Foundation have used artificial intelligence to analyse datasets from Huntington’s disease observational trials to model progression of the disease. They hope their findings will help improve clinical trial design.
-
A new roadmap to track Huntington’s disease progression
7 min read
Researchers have updated the system that classifies Huntington’s disease progression. Tracking progression in 4 stages will make clinical trial screening and data interpretation easier and faster, and pave the way for pre-symptomatic trials.
-
A spoonful of branaplam helps the huntingtin go down
7 min read
Branaplam was originally designed to treat spinal muscular atrophy, but a new paper outlines how it could hold promise for treating Huntington’s. This oral drug lowers huntingtin protein and will now be tested in a study called VIBRANT-HD.
-
Huntington’s disease therapeutics conference 2022 – Day 3
25 min read
Check out research updates from Day 3 of the 2022 HD Therapeutics Conference #HDTC2022
-
Huntington’s disease therapeutics conference 2022 – Day 1
23 min read
Check out research updates from Day 1 of the 2022 HD Therapeutics Conference #HDTC2022
-
Huntington’s disease therapeutics conference 2022 – Day 2
13 min read
Check out research updates from Day 2 of the 2022 HD Therapeutics Conference #HDTC2022
-
Shining a spotlight on huntingtin: a tool to measure huntingtin-lowering in real time
7 min read
A new imaging tool means that scientists can now directly measure the levels of the toxic huntingtin protein in animal models of Huntington’s disease, letting us see how well huntingtin lowering therapies are working in their brains
-
Oral drug may change the story for huntingtin lowering
8 min read
Researchers with PTC Therapeutics recently published exciting new findings – a promising new huntingtin lowering drug that can be taken as a pill. Will this change how we move forward with huntingtin lowering?
-
Finding the silver lining: an update on the Roche GENERATION-HD1 trial data
10 min read
The first round of findings from the halted tominersen huntingtin lowering trial, GENERATION-HD1, run by Roche were shared this week with the HD community. HDBuzz explains what they found and what’s next.